MedTrace Logo

Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults

NCT01362699 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2012-04-30

No results posted yet for this study

Summary

The purpose of this study is to assess whether JNJ-31001074 taken for 7 days reduces the urge to drink alcohol in alcohol-dependent study participants who are not seeking treatment.

Conditions

  • Alcoholism

Interventions

DRUG

JNJ-31001074

Type=exact number, unit=mg, number=3, form=tablet, route=oral use. One tablet once daily for 7 days.

DRUG

Placebo

Form=tablet, route=oral administration. One tablet once daily for 7 days.

Sponsors & Collaborators

  • The Scripps Research Institute

    collaborator OTHER

  • Janssen Research & Development, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Research & Development, LLC C. Clinical Trial · Janssen Research & Development, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01362699 on ClinicalTrials.gov